カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の5-in-1 DTaP-Hib-IPVワクチン市場2023年：企業・地域・タイプ・用途別分析

◆英語タイトル：Global 5-in-1 DTaP-Hib-IPV Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書（GIR23SM7757）◆商品コード：GIR23SM7757
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年9月
◆ページ数：79
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の5-in-1 DTaP-Hib-IPVワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の5-in-1 DTaP-Hib-IPVワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 5-in-1 DTaP-Hib-IPVワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

5-in-1 DTaP-Hib-IPVワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・8ヶ月、18ヶ月

用途別セグメント
・病院、コミュニティ

主要な市場プレーヤー
・Sanofi Pasteur

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、5-in-1 DTaP-Hib-IPVワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な5-in-1 DTaP-Hib-IPVワクチンメーカーの企業概要、2019年～2022年までの5-in-1 DTaP-Hib-IPVワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な5-in-1 DTaP-Hib-IPVワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別5-in-1 DTaP-Hib-IPVワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの5-in-1 DTaP-Hib-IPVワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での5-in-1 DTaP-Hib-IPVワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および5-in-1 DTaP-Hib-IPVワクチンの産業チェーンを掲載しています。
・第14、15章では、5-in-1 DTaP-Hib-IPVワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 5-in-1 DTaP-Hib-IPVワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：8ヶ月、18ヶ月
– 用途別分析（2018年vs2022年vs2029年）：病院、コミュニティ
– 世界の5-in-1 DTaP-Hib-IPVワクチン市場規模・予測
– 世界の5-in-1 DTaP-Hib-IPVワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sanofi Pasteur
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：8ヶ月、18ヶ月
・用途別分析2018年-2029年：病院、コミュニティ
・5-in-1 DTaP-Hib-IPVワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・5-in-1 DTaP-Hib-IPVワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・5-in-1 DTaP-Hib-IPVワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・5-in-1 DTaP-Hib-IPVワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・5-in-1 DTaP-Hib-IPVワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of 5-in-1 DTaP-Hib-IPV Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 8-month
1.3.3 18-month
1.4 Market Analysis by Application
1.4.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Community
1.5 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size & Forecast
1.5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (2018-2029)
1.5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Product and Services
2.1.4 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
3 Competitive Environment: 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer
3.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
3.5 5-in-1 DTaP-Hib-IPV Vaccine Market: Overall Company Footprint Analysis
3.5.1 5-in-1 DTaP-Hib-IPV Vaccine Market: Region Footprint
3.5.2 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Type Footprint
3.5.3 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
4.1.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2018-2029)
4.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.5 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2018-2029)
5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
6.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2018-2029)
6.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
7.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
7.3 North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
7.3.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
8.3.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
9.3.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
10.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
10.3 South America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
10.3.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
11.3.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 5-in-1 DTaP-Hib-IPV Vaccine Market Drivers
12.2 5-in-1 DTaP-Hib-IPV Vaccine Market Restraints
12.3 5-in-1 DTaP-Hib-IPV Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of 5-in-1 DTaP-Hib-IPV Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of 5-in-1 DTaP-Hib-IPV Vaccine
13.3 5-in-1 DTaP-Hib-IPV Vaccine Production Process
13.4 5-in-1 DTaP-Hib-IPV Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 5-in-1 DTaP-Hib-IPV Vaccine Typical Distributors
14.3 5-in-1 DTaP-Hib-IPV Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Product and Services
Table 6. Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 9. Global 5-in-1 DTaP-Hib-IPV Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 10. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 11. Market Position of Manufacturers in 5-in-1 DTaP-Hib-IPV Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 12. Head Office and 5-in-1 DTaP-Hib-IPV Vaccine Production Site of Key Manufacturer
Table 13. 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Type Footprint
Table 14. 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Application Footprint
Table 15. 5-in-1 DTaP-Hib-IPV Vaccine New Market Entrants and Barriers to Market Entry
Table 16. 5-in-1 DTaP-Hib-IPV Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 18. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 19. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 20. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 21. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 22. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 23. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 24. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 25. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 26. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 27. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 28. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 29. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 30. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 31. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 32. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 33. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 34. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 35. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 36. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 37. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 38. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 39. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 40. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 41. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 42. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 43. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 46. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 47. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 48. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 49. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 50. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 51. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 52. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 53. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 54. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 55. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 56. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 57. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 58. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 59. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 60. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 61. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 62. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 63. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 64. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 65. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 66. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 67. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 68. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 69. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 72. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 73. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 74. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 75. 5-in-1 DTaP-Hib-IPV Vaccine Raw Material
Table 76. Key Manufacturers of 5-in-1 DTaP-Hib-IPV Vaccine Raw Materials
Table 77. 5-in-1 DTaP-Hib-IPV Vaccine Typical Distributors
Table 78. 5-in-1 DTaP-Hib-IPV Vaccine Typical Customers
List of Figures
Figure 1. 5-in-1 DTaP-Hib-IPV Vaccine Picture
Figure 2. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Type in 2022
Figure 4. 8-month Examples
Figure 5. 18-month Examples
Figure 6. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Community Examples
Figure 10. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. 5-in-1 DTaP-Hib-IPV Vaccine Market Drivers
Figure 73. 5-in-1 DTaP-Hib-IPV Vaccine Market Restraints
Figure 74. 5-in-1 DTaP-Hib-IPV Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of 5-in-1 DTaP-Hib-IPV Vaccine in 2022
Figure 77. Manufacturing Process Analysis of 5-in-1 DTaP-Hib-IPV Vaccine
Figure 78. 5-in-1 DTaP-Hib-IPV Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の5-in-1 DTaP-Hib-IPVワクチン市場2023年：企業・地域・タイプ・用途別分析(Global 5-in-1 DTaP-Hib-IPV Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • DTaP＆Tdapワクチンの世界市場見通し2023年-2029年
  • 世界の5-フルオシトシン医薬品市場2023年：企業・地域・タイプ・用途別分析
  • 世界の5.0中性ホウケイ酸ガラスアンプル市場2023年：企業・地域・タイプ・用途別分析
  • 世界の5-ペンチルジヒドロフラン-2（3H）-オン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の5-クロロ-2-ペンタノン市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆